{"id":"W4402630414","doi":"10.1016/s1474-4422(24)00328-4","title":"Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Merck KGaA; Merck","keywords":"Multiple sclerosis; Medicine; Physical therapy; Phase (matter); Double blind; Physical medicine and rehabilitation; Internal medicine; Alternative medicine; Placebo; Psychiatry; Pathology; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003677119,0.0002468403,0.001645196,0.0002844996,0.0001169346,0.00003484171,0.0001656033,0.0001723322,0.00007155223],"category_scores_gemma":[0.00363493,0.0001596028,0.0001766358,0.0003982506,0.0005488239,0.0001152909,0.0001648124,0.000681943,0.0000131373],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005972333,"about_ca_system_score_gemma":0.001085766,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005781377,"about_ca_topic_score_gemma":0.0001961848,"domain_scores_codex":[0.9964948,0.001120801,0.000942104,0.000546863,0.000313861,0.0005816257],"domain_scores_gemma":[0.9897202,0.009376334,0.0002006202,0.0004791088,0.00008178335,0.0001419396],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9666688,0.0003173538,0.0005355867,0.0002171609,0.0003848512,0.0001187737,0.001003795,0.0002285187,0.01160928,0.0007910793,0.0003067744,0.01781801],"study_design_scores_gemma":[0.8708415,0.0004391937,0.003845272,0.0002126394,0.0003755931,0.0002775737,0.00004411061,0.1216908,0.0006876251,0.0001478567,0.001315697,0.0001220786],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806663,0.008753114,0.0001908438,0.00589108,0.0003499672,0.003599331,0.00003847422,0.00007680309,0.0004340281],"genre_scores_gemma":[0.9951683,0.003613878,0.0001509898,0.0002980328,0.0004915392,0.0001152018,0.00001891852,0.00003480229,0.0001083666],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1214623,"threshold_uncertainty_score":0.6508413,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.123330611644483,"score_gpt":0.3887133599125956,"score_spread":0.2653827482681126,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}